Stocks
1 Compelling Reason to Invest in Eli Lilly Stock Immediately
In September, Lilly achieved another significant milestone by securing FDA approval for Ebglyss, an injectable treatment for moderate-to-severe eczema.
Stocks
In September, Lilly achieved another significant milestone by securing FDA approval for Ebglyss, an injectable treatment for moderate-to-severe eczema.
Stocks
Today, we highlight two healthcare stocks, Walgreens Boots Alliance and CVS Health, which may disappoint investors in the near term.
Stocks
Joyner, who previously held executive positions within CVS, takes over from Karen Lynch, who has been in the role since February 2021. With 37 years of industry experience, Joyner expressed his commitment to enhancing the health-focused mission of CVS alongside its 300,000 employees.
Nvidia
With its stock up 238% last year and an optimistic revenue forecast of $58.7 billion, Nvidia cements its status as a leader in AI and gaming, making it a top pick for investors in 2024.